Amedisys Net Income
| AMEDDelisted Stock | USD 100.99 0.03 0.03% |
As of the 4th of February, Amedisys shows the risk adjusted performance of 0.0976, and Mean Deviation of 0.4196. Amedisys technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Amedisys downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Amedisys is priced correctly, providing market reflects its regular price of 100.99 per share. Given that Amedisys has jensen alpha of 0.0776, we suggest you to validate Amedisys's prevailing market performance to make sure the company can sustain itself at a future point.
Amedisys' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amedisys' valuation are provided below:Amedisys does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Amedisys |
Search Suggestions
| AM | Antero Midstream Partners | Company |
| AMTPQ | Ameritrans Capital Corp | Company |
| AMECX | Income Fund Of | Mutual Fund |
| AMJ | JPMorgan | ETF |
| AMZ | Alerian MLP Index | Index |
| AMO | AMO | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Amedisys reported net income of 38.16 M. This is 88.82% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 93.32% higher than that of the company.
Amedisys Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amedisys' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics of similar companies.Amedisys is currently under evaluation in net income category among its peers.
Amedisys Fundamentals
| Return On Equity | 0.0667 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 3.43 B | |||
| Shares Outstanding | 32.89 M | |||
| Shares Owned By Insiders | 1.95 % | |||
| Shares Owned By Institutions | 96.30 % | |||
| Number Of Shares Shorted | 3.2 M | |||
| Price To Earning | 15.03 X | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 1.38 X | |||
| Revenue | 2.35 B | |||
| Gross Profit | 1.04 B | |||
| EBITDA | 73.45 M | |||
| Net Income | 38.16 M | |||
| Cash And Equivalents | 17.96 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 460.18 M | |||
| Debt To Equity | 0.53 % | |||
| Current Ratio | 1.06 X | |||
| Book Value Per Share | 37.48 X | |||
| Cash Flow From Operations | 221.66 M | |||
| Short Ratio | 6.84 X | |||
| Earnings Per Share | 2.57 X | |||
| Price To Earnings To Growth | 1.47 X | |||
| Target Price | 95.2 | |||
| Number Of Employees | 19 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 3.32 B | |||
| Total Asset | 2.14 B | |||
| Retained Earnings | 791.16 M | |||
| Working Capital | 117.69 M | |||
| Current Asset | 175.26 M | |||
| Current Liabilities | 175.19 M | |||
| Net Asset | 2.14 B |
About Amedisys Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amedisys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Amedisys Stock
If you are still planning to invest in Amedisys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedisys' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |